Semaglutide Alleviates Ovary Inflammation via the AMPK/SIRT1/NF‑κB Signaling Pathway in Polycystic Ovary Syndrome Mice
Drug Design, Development and Therapy · 2024-09 · Volume 18 · 3925-3938
DOI: 10.2147/dddt.s484531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024-09. Verfasst von Mei Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China. Hauptthemen laut MEDLINE: Glucagon-Like Peptides, Inflammation, Polycystic Ovary Syndrome, Signal Transduction. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China.
- Department of Ultrasound Medicine, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China.
- Department of Gastroenterology, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China.
- Department of Interventional Vascular Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China.
- Department of Clinical Laboratory, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China.
- Department of Pathology, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China.
ORCID-Profile: Lei Han
Zitieren
APA
Liu, M., Guo, S., Li, X., Tian, Y., Yu, Y., Tang, L., Sun, Q., Zhang, T., Fan, M., Zhang, L., Xu, Y., An, J., Gao, X., Han, L., & Zhang, L. (2024). Semaglutide Alleviates Ovary Inflammation via the AMPK/SIRT1/NF‑κB Signaling Pathway in Polycystic Ovary Syndrome Mice. Drug Design, Development and Therapy, Volume 18, 3925-3938. https://doi.org/10.2147/dddt.s484531
Vancouver
Liu M, Guo S, Li X, Tian Y, Yu Y, Tang L, et al. Semaglutide Alleviates Ovary Inflammation via the AMPK/SIRT1/NF‑κB Signaling Pathway in Polycystic Ovary Syndrome Mice. Drug Design, Development and Therapy. 2024;Volume 18:3925-3938. doi:10.2147/dddt.s484531
BibTeX
@article{Liu2024,
author = {Liu, Mei and Guo, Sili and Li, Xiaohan and Tian, Yang and Yu, Yanjie and Tang, Lili and Sun, Qimei and Zhang, Ting and Fan, Mingwei and Zhang, Lili and Xu, Yingjiang and An, Jiajia and Gao, Xiangqian and Han, Lei and Zhang, Lei},
title = {Semaglutide Alleviates Ovary Inflammation via the AMPK/SIRT1/NF‑κB Signaling Pathway in Polycystic Ovary Syndrome Mice},
journal = {Drug Design, Development and Therapy},
year = {2024},
volume = {Volume 18},
pages = {3925--3938},
doi = {10.2147/dddt.s484531}
}
EUVIMED